Barclays PLC Sensus Healthcare, Inc. Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Barclays PLC holds 2,738 shares of SRTS stock, worth $11,828. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,738
Previous 2,738
-0.0%
Holding current value
$11,828
Previous $13,000
38.46%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SRTS
# of Institutions
46Shares Held
4.22MCall Options Held
18.7KPut Options Held
28.7K-
Vanguard Group Inc Valley Forge, PA729KShares$3.15 Million0.0% of portfolio
-
Pacific Ridge Capital Partners, LLC Lake Oswego, OR573KShares$2.48 Million0.44% of portfolio
-
Dimensional Fund Advisors LP Austin, TX569KShares$2.46 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL453KShares$1.96 Million0.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny261KShares$1.13 Million0.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $71.5M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...